521 |
Achmea BV SWOT Analysis
|
Serial
|
-Empty-
|
-Empty-
|
EBSCOhost
|
2024-06-29 20:04
|
Current
|
https://search.ebscohost.com/direct.asp?db=ent&jid=FVB3&scope=site
|
522 |
Ackermans & Van Haaren NV SWOT Analysis
|
Serial
|
-Empty-
|
-Empty-
|
EBSCOhost
|
2024-06-29 20:04
|
Current
|
https://search.ebscohost.com/direct.asp?db=ent&jid=L74R&scope=site
|
523 |
Ackermans & van Haaren NV MarketLine Company Profile
|
Serial
|
-Empty-
|
-Empty-
|
EBSCOhost
|
2024-06-29 20:04
|
Current
|
https://search.ebscohost.com/direct.asp?db=ent&jid=HSV0&scope=site
|
524 |
Acme United Corporation MarketLine Company Profile
|
Serial
|
-Empty-
|
-Empty-
|
EBSCOhost
|
2024-06-29 20:04
|
Current
|
https://search.ebscohost.com/direct.asp?db=ent&jid=HSV1&scope=site
|
525 |
Acme United Corporation SWOT Analysis
|
Serial
|
-Empty-
|
-Empty-
|
EBSCOhost
|
2024-06-29 20:04
|
Current
|
https://search.ebscohost.com/direct.asp?db=ent&jid=L74S&scope=site
|
526 |
Acom Co., Ltd. MarketLine Company Profile
|
Serial
|
-Empty-
|
-Empty-
|
EBSCOhost
|
2024-06-29 20:04
|
Current
|
https://search.ebscohost.com/direct.asp?db=ent&jid=HSV2&scope=site
|
527 |
Acom Co., Ltd. SWOT Analysis
|
Serial
|
-Empty-
|
-Empty-
|
EBSCOhost
|
2024-06-29 20:04
|
Current
|
https://search.ebscohost.com/direct.asp?db=ent&jid=152I&scope=site
|
528 |
Acorda Therapeutics SWOT Analysis
|
Serial
|
-Empty-
|
-Empty-
|
EBSCOhost
|
2024-06-29 20:04
|
Current
|
https://search.ebscohost.com/direct.asp?db=ent&jid=53D9&scope=site
|
529 |
Acorda Therapeutics, Inc SWOT Analysis
|
Serial
|
-Empty-
|
-Empty-
|
EBSCOhost
|
2024-06-29 20:04
|
Current
|
https://search.ebscohost.com/direct.asp?db=ent&jid=LH2V&scope=site
|
530 |
Acorda Therapeutics, Inc. MarketLine Company Profile
|
Serial
|
-Empty-
|
-Empty-
|
EBSCOhost
|
2024-06-29 20:04
|
Current
|
https://search.ebscohost.com/direct.asp?db=ent&jid=HSV3&scope=site
|